Rainbow Childrens Medicare has scheduled an earnings conference call for July 31, 2026, to discuss its financial and operating performance for the quarter ended June 30, 2026. The event provides investors and analysts with a direct channel to review the company’s Q1FY27 results and strategic direction. This disclosure ensures transparency regarding the firm’s recent operational outcomes ahead of broader market commentary.

The announcement was made pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirement) Regulations 2015. Shreya Mitra, Company Secretary and Compliance Officer, issued the intimation on July 23, 2026. The filing was submitted to both the National Stock Exchange of India Limited and BSE Limited.

Conference Call Details

The conference call is set for Friday, July 31, 2026, at 10:00 AM IST. IIFL Capital Markets will facilitate the event, providing dial-in options for participants across India and international markets including the USA, UK, Singapore, and Hong Kong. A pre-registration link via Diamond Pass is available for attendees.

Management Participants

The discussion will feature key executives from Rainbow Childrens Medicare Limited. The panel includes leadership responsible for overall strategy, financial oversight, and investor relations.

• Dr. Ramesh Kancharla, Chairman and MD
• Abrar Ali Dalal, Group Chief Executive Officer
• Vikas Maheshwari, Group Chief Financial Officer
• Saurabh Bhandari, Head IR & Business Intelligence

Investor Contact Information

For further information regarding the conference call or corporate inquiries, investors may contact the designated representatives at IIFL Capital Markets:

• Rahul Jeewani: +91 22 4646 4673
• Naman Bagrecha: +91 22 4646 4718
• Aman Goyal: +91 22 4646 4705
• Vighnesh Indure: +91 22 4646 4661

The company maintains its registered office in Banjara Hills, Hyderabad, and operates hospitals across Bengaluru, Chennai, Delhi, Guwahati, Hyderabad, Rajahmundry, Vijayawada, Visakhapatnam, and Warangal.

Rainbow Childrens Medicare Limited has improved its Environmental, Social, and Governance (ESG) standing, securing a 'Strong' rating for FY 2025-26. CRISIL ESG Rating & Analytics Limited assigned the company an overall ESG rating of 61 and a Core ESG rating of 73 based on disclosures for the financial year. This upgrade reflects a shift from the 'Adequate' rating the company held for FY 2024-25 and FY 2023-24, signaling better performance in sustainability practices.

The assessment was carried out on a voluntary basis on July 22, 2026. It is important to note that the company did not engage CRISIL ESG for this evaluation. Instead, the rating agency independently prepared the report relying solely on data pertaining to FY 2025-26 available in the public domain.

ESG Rating Details

The following table outlines the specific ratings assigned by CRISIL ESG for the period:

The improvement in the overall ESG score to 61 indicates enhanced integration of ESG factors compared to previous years. The Core ESG rating of 73 further highlights the company's strength in fundamental governance and social metrics.